Skip to main
IMGN
IMGN logo

ImmunoGen (IMGN) Earnings Dates & Reports

ImmunoGen (IMGN) Most Recent Earnings

Report DateNov 2, 2023
Period EndingQ3 2023
Est. EPS$0.04
Actual EPS$0.10
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

ImmunoGen (IMGN) Earnings per Share (EPS) History

Signup for full access
Browse free

ImmunoGen (IMGN) Latest Earnings

The value each IMGN share was expected to gain vs. the value each share gained.

ImmunoGen (IMGN) reported its most recent earnings on Nov 2, 2023 for Q3 2023, posting earnings per share (EPS) of $0.10. This exceeded analysts' expectations of $0.04 by 150.00%, marking a Beat.

For comparison, ImmunoGen reported EPS of -$0.31 in the same quarter last year.

The company is expected to announce its next earnings report on 11/02/2023, with analysts projecting an EPS of $0.

ImmunoGen (IMGN) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2023Nov 2, 2023
$0.04$0.10+150.00%
Q2 2023Jul 31, 2023
-$0.16-$0.02-87.50%
Q1 2023Apr 28, 2023
-$0.25-$0.16-36.00%
Q4 2022Mar 1, 2023
-$0.30-$0.23-23.33%
Q3 2022Nov 4, 2022
-$0.25-$0.31+24.00%
View all

ImmunoGen (IMGN) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the ImmunoGen’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Jul 31, 2023
Apr 28, 2023
Mar 1, 2023
Nov 4, 2022

ImmunoGen (IMGN) Earnings FAQs

ImmunoGen (IMGN) last reported earnings on Nov 2, 2023 for Q3 2023, posting an EPS of $0.10, which Beat the estimate of $0.04 by 150.00%.

For Q3 2023, ImmunoGen (IMGN) reported an EPS of $0.10, exceeding analysts' estimate of $0.04 by 150.00%.

For Q3 2023, ImmunoGen (IMGN) Beat expectations with an actual EPS of $0.10 vs. an estimated EPS of $0.04.

Following the last earnings report on Nov 2, 2023, ImmunoGen (IMGN)'s stock price moved — from — to —.

The next ImmunoGen (IMGN) earnings call is scheduled for Nov. 2, 2023, where executives will discuss financial results and outlook.

ImmunoGen (IMGN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.